(UHS) Universal Health Services, Inc. Company Overview

US | Healthcare | Medical - Care Facilities | NYSE

(UHS) Universal Health Services, Inc. Bundle

Get Full Bundle:
$9 $5
$9 $5
$9 $5
$19 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5

TOTAL:

What does Universal Health Services do?

Universal Health Services, Inc. is a publicly traded hospital and healthcare-services holding company listed on the New York Stock Exchange under the ticker UHS. Through operating subsidiaries, it owns and manages acute-care hospitals, freestanding emergency departments, behavioral-health facilities, outpatient sites, physician practices, an insurance offering and related management services. The company’s official company overview describes a network built around local care delivery rather than a single national consumer brand.

$17.36B
Net revenue, FY2025
375
Inpatient facilities, February 25, 2026
168
Outpatient and other facilities, February 25, 2026
101,500
Approximate employees, Q1 2026 company profile

How broad is the operating footprint?

As of February 25, 2026, UHS owned or operated 29 inpatient acute-care hospitals and 346 inpatient behavioral-health facilities, together with 168 outpatient facilities and ambulatory access points. Its footprint spans 40 states, Washington, D.C., Puerto Rico and the United Kingdom. The behavioral network is much larger by facility count, while acute care is concentrated in fewer, larger regional hospital systems. That structure matters because the two businesses have different lengths of stay, staffing models, payer mixes, capital needs and margins.

Operating dimension Officially reported scale Why it matters
Acute care 29 inpatient hospitals; 35 freestanding emergency departments; 13 outpatient centers plus one surgical hospital Large regional systems generate the majority of revenue and require substantial capital spending.
Behavioral health 346 inpatient and 119 outpatient facilities A broad network addresses psychiatric, addiction and specialty behavioral needs across multiple settings.
Clinical activity 5.8 million patient encounters and 8.13 million patient days, FY2025 Scale supports purchasing, administration, recruiting and payer contracting, but also magnifies labor and compliance exposure.
Workforce About 101,500 employees, including more than 25,800 nurses, FY2025/Q1 2026 profile Healthcare is labor intensive; staffing availability and wage inflation directly affect margins and capacity.

Why does the two-segment mix matter?

The 2025 annual report shows that acute care produced the larger revenue base, but behavioral health delivered the higher segment margin. This creates a useful portfolio balance: acute hospitals provide scale, local market density and high-acuity services, while behavioral facilities contribute a more profitable earnings stream and exposure to sustained demand for mental-health and substance-use treatment.

How does UHS make money, and which segment matters most?

UHS earns revenue when its facilities deliver inpatient, outpatient, emergency, surgical, psychiatric and related services. Payment comes from commercial insurers, managed-care plans, Medicare, Medicaid, patients and government-supported supplemental programs. The economic chain is straightforward, but the pricing is not: revenue depends on negotiated rates, government reimbursement formulas, patient volume, treatment intensity, payer mix and the ability to collect receivables.

1. Local access
Hospitals, emergency sites, outpatient centers and behavioral facilities attract patients through community presence and referral networks.
2. Clinical activity
Admissions, patient days, procedures, emergency visits and outpatient encounters create billable services.
3. Reimbursement
Commercial contracts and government programs translate activity, acuity and payer mix into net revenue.
4. Margin conversion
Labor, supplies, facility costs, provider taxes, depreciation and interest determine operating cash generation.

Which segment generates more revenue?

Reportable segment revenue mix — FY2025
Acute Care Services — $9.93B, 57.2% of reportable segment revenue
Behavioral Health Care Services — $7.43B, 42.8% of reportable segment revenue
The calculation uses $17.35B of FY2025 reportable segment revenue; approximately $13.4M of non-segment revenue is excluded.
Segment FY2025 revenue FY2025 income before taxes Segment margin Economic role
Acute Care Services $9.93B $1.05B 10.5% Largest revenue source; performance depends on local market share, acuity, commercial pricing and capacity utilization.
Behavioral Health Care Services $7.43B $1.46B 19.7% Higher-margin earnings engine with longer stays, broad facility density and specialized treatment programs.
Consolidated company $17.36B $1.99B operating income 11.5% operating margin Combines segment economics with corporate costs, depreciation, interest and noncontrolling interests.

Why does behavioral health produce more segment profit?

FY2025
segment profit
Behavioral Health — $1.46B, 58.2% of combined segment income before taxes
Acute Care — $1.05B, 41.8% of combined segment income before taxes

Behavioral health generated less revenue but more combined segment income before taxes in FY2025. Its 19.7% margin was almost double acute care’s 10.5%. This does not make the segment risk-free: behavioral facilities are highly exposed to staffing availability, regulatory scrutiny, clinical quality and reimbursement. It does mean that incremental behavioral growth can have an outsized effect on consolidated earnings if UHS preserves occupancy, pricing and labor productivity.

Behavioral-health scale and acute-care density define the portfolio

UHS is not simply a collection of unrelated hospitals. Its strategy is to build or acquire high-quality facilities in growing markets, invest in staff and equipment, and become a leading provider within each community. The acute-care side benefits from dense regional systems and high barriers to building new hospitals. The behavioral side benefits from a national and international network, specialized programs and a large base of referral relationships.

Acute-care position
29 hospitals
Q1 2026 profile. Fewer but larger assets, with emergency, surgical and outpatient access points clustered around regional systems.
Behavioral-health position
346 facilities
Q1 2026 profile. A broad inpatient network across the United States, the United Kingdom and Puerto Rico.

Where does UHS compete?

In acute care, UHS competes with national for-profit systems such as HCA Healthcare, Tenet Healthcare and Community Health Systems, as well as nonprofit and public hospital systems that may have strong local physician networks or tax advantages. In behavioral health, Acadia Healthcare is the closest large public-company comparison, while regional operators, nonprofit providers and virtual platforms compete for patients, clinicians and payer contracts. The company’s acute-care operations emphasize full-service community hospitals and access points, while its behavioral-health operations span psychiatric, substance-use and specialty programs.

Lower scale / general care
Independent local providers may know their markets well but lack UHS purchasing, capital and administrative scale.
High scale / acute focused
Large hospital systems can match or exceed acute-care density in selected markets.
Specialized / narrower footprint
Focused behavioral operators may compete intensely for clinical talent and payer referrals.
UHS: high scale / dual platform
UHS combines a large acute revenue base with one of the broadest behavioral-health networks, reducing dependence on a single care setting.
Positioning is an analytical classification based on UHS’s disclosed operating footprint, not an official market-share ranking.

What is the practical moat?

The moat is operational rather than technological. Hospitals require licenses, specialized labor, capital, compliance systems and established payer relationships. Dense local networks can keep referrals and outpatient activity inside the system, while centralized purchasing and administration spread overhead across hundreds of facilities. Behavioral-health scale adds program breadth and referral capacity. The constraint is that scale does not eliminate local competition: each hospital must maintain quality, clinician relationships and an attractive payer mix. UHS’s advantage is strongest where it has regional density and scarce capacity, not merely because the corporate network is large.

What does the latest quarter show?

The freshest official results are for the three months ended March 31, 2026. UHS reported revenue growth, higher operating income and faster diluted EPS growth, while adjusted EBITDA margin edged lower. The Q1 2026 earnings release and the related Form 10-Q show a business still benefiting more from reimbursement and mix than from rapid admission growth.

$4.50B
Revenue, Q1 2026; up 9.6% year over year
$502.9M
Operating income, Q1 2026; 11.2% operating margin
$348.7M
Net income attributable to UHS, Q1 2026
$5.65
Diluted EPS, Q1 2026; versus $4.80 in Q1 2025
14.4%
Adjusted EBITDA margin, Q1 2026. Adjusted EBITDA net of noncontrolling interests was $648.3M, up from $598.2M in Q1 2025, but the margin was about 14.4% versus 14.6% a year earlier. Growth therefore remained solid without a broad consolidated margin expansion.

What changed in Q1 2026?

Metric Q1 2026 Q1 2025 Interpretation
Net revenue $4.50B $4.10B 9.6% growth, supported by both segments and higher revenue per adjusted unit.
Operating income $502.9M $454.8M Operating income grew about 10.6%, slightly faster than revenue.
Adjusted EBITDA net of NCI $648.3M $598.2M 8.4% growth; margin eased by roughly 20 basis points.
Operating cash flow $401.6M $360.0M Cash generation improved by about $41.6M, partly because receivable timing was more favorable.
Capital expenditures $217.2M $239.0M Lower quarterly spending lifted the simple operating-cash-flow-minus-capex proxy to $184.5M.
Days sales outstanding 55 days 53 days Collections remain a key working-capital variable despite stronger quarterly cash flow.
Q1 2026 segment revenue
Acute Care Services$2.61B
Behavioral Health Care Services$1.88B
Acute care remained the larger revenue contributor in Q1 2026; bar lengths are indexed to acute-care revenue as 100%.

Was growth volume-led or price-led?

The answer is mostly price, acuity and payer mix, with modest volume support. On a same-facility basis, acute-care adjusted admissions were unchanged and adjusted patient days increased 0.8%, yet revenue rose 8.2% because net revenue per adjusted admission increased 6.3%. Behavioral-health adjusted admissions rose 1.2% and adjusted patient days 1.6%, while revenue per adjusted admission increased 6.2%. The latest quarter therefore shows that UHS’s near-term growth depends heavily on reimbursement yield and service mix, not only on adding patients.

Pricing, patient volume and labor mix drive hospital economics

Hospital revenue growth is valuable only when it exceeds the growth in wages, supplies, facility costs and uncompensated care. UHS’s two segments use different operating scorecards, but both require analysts to separate patient volume from revenue per patient. A quarter with flat admissions can still be strong if acuity and reimbursement improve; the reverse is also true when low-paying volume rises faster than pricing.

Which operating metrics explain acute care?

Acute-care same-facility drivers — Q1 2026 year-over-year change
Revenue+8.2%
Revenue per adjusted admission+6.3%
Adjusted patient days+0.8%
Adjusted admissions0.0%
Scale is normalized to 10 percentage points for visual comparison; the 0.0% admission row uses the required minimum visible sliver and the label states no growth.

Acute-care same-facility occupancy of available beds was about 69.1% in Q1 2026, while average length of stay was 4.9 days. Salary expense improved to 37.3% of all acute-care revenue from 38.8% a year earlier, but other operating expense rose to 32.9% from 30.4%. The margin implication is mixed: labor productivity improved, while non-labor costs and new-facility ramp expenses absorbed part of the gain.

Which metrics explain behavioral care?

Behavioral-health facilities operate with much longer stays and a different staffing intensity. Same-facility average length of stay was 13.7 days in Q1 2026, available-bed occupancy was about 74.0%, adjusted admissions increased 1.2% and adjusted patient days increased 1.6%. Salary expense represented 54.6% of same-facility behavioral revenue, making clinician recruitment, retention and scheduling the central cost variable.

KPI Q1 2026 signal How to interpret it
Adjusted admissions Acute 0.0%; behavioral +1.2% Shows demand after adjusting inpatient activity for outpatient volume; weak growth increases dependence on price and mix.
Adjusted patient days Acute +0.8%; behavioral +1.6% Captures both patient count and duration; it is particularly important in behavioral care.
Revenue per adjusted admission Acute +6.3%; behavioral +6.2% A proxy for pricing, acuity and payer mix; it drove most of Q1 2026 same-facility revenue growth.
Available-bed occupancy Acute 69.1%; behavioral 74.0% Higher utilization spreads fixed facility costs, but excessive occupancy can strain staffing and service quality.
Length of stay Acute 4.9 days; behavioral 13.7 days Longer stays raise patient days but must remain clinically appropriate and reimbursable.
Salary ratio Acute 37.3%; behavioral 53.2% on all-facility revenue The clearest operating-leverage measure: a rising ratio signals wage pressure or insufficient volume and pricing.

How financially strong is UHS?

UHS is profitable and cash generative, but it is also capital intensive and meaningfully leveraged. Its financial strength comes from diversified operating cash flow and access to credit rather than from a large net-cash balance. The analytical task is to distinguish recurring cash generation from working-capital timing and to judge whether buybacks, acquisitions and new facilities leave enough balance-sheet flexibility.

$119.0M
Cash and cash equivalents, March 31, 2026
$4.71B
Total debt, March 31, 2026
$7.46B
UHS stockholders’ equity, March 31, 2026
1.70x
Debt to trailing EBITDA net of NCI, March 31, 2026

How much cash does the business produce?

$401.6M
Operating cash flow, Q1 2026
$217.2M
Less capital expenditures, Q1 2026
$184.5M
Simple cash-flow proxy after capex, Q1 2026

For FY2025, operating cash flow was $1.86B and additions to property and equipment were $1.02B, leaving a simple $849.2M operating-cash-flow-minus-capex proxy. This is not identical to management’s non-GAAP free cash flow because acquisition spending, asset sales, working-capital timing and other classifications may differ. It is nevertheless useful for understanding how much internally generated cash remained before dividends, buybacks and debt changes.

How much leverage and reinvestment must it carry?

At March 31, 2026, debt represented 38.7% of total capital, down from 40.7% a year earlier. UHS also had about $373M drawn on its revolving credit facility. In April 2026, it expanded borrowing capacity by $900M, including a $400M delayed-draw term loan expected to help fund the proposed Talkspace acquisition. Management’s FY2026 capital-spending expectation was $950M to $1.10B, broadly consistent with the approximately $1.02B invested in FY2025.

Profitability: $1.49B attributable net income, FY2025Strong
Cash generation: $1.86B operating cash flow, FY2025Strong
Leverage: 1.70x debt to trailing EBITDA net of NCI, March 31, 2026Moderate
Capital intensity: $950M–$1.10B expected capex, FY2026Demanding

What turning points still shape UHS today?

The most useful history is the history that explains today’s segment mix, control structure and growth strategy. UHS’s official timeline shows a pattern of using acquisitions and new facilities to enter markets, then applying a decentralized operating model backed by corporate capital and systems.

  1. 1979
    Founding and first hospital operations. Alan B. Miller established UHS in King of Prussia, Pennsylvania. The community-hospital model and founder influence remain central to strategy and governance.
  2. 1980
    Initial public offering. Public capital gave UHS a platform for acquisitions and facility investment while the multi-class structure preserved concentrated voting influence.
  3. 1983
    Qualicare acquisition. The transaction added acute and psychiatric facilities and established behavioral health as a durable second operating platform.
  4. 1997
    George Washington University Hospital partnership and Service Excellence. The company expanded its institutional partnerships while formalizing an operating philosophy centered on patient service and accountability.
  5. 2010
    Psychiatric Solutions acquisition. The approximately $3.1B transaction, including debt, transformed the scale of the behavioral-health portfolio and explains why behavioral care now produces more segment profit than acute care.
  6. 2014
    Cygnet acquisition in the United Kingdom. UHS added 17 facilities and 743 beds, creating an international behavioral platform and exposure to UK reimbursement, regulation and currency.
  7. 2021
    CEO succession. Marc D. Miller became chief executive while Alan Miller remained Executive Chairman, preserving family continuity within a public-company structure.
  8. 2024–2026
    New hospitals and digital behavioral expansion. West Henderson Hospital opened in December 2024, Cedar Hill Regional Medical Center opened in April 2025, and UHS announced the proposed Talkspace acquisition in March 2026.

How did acquisitions change the strategic mix?

The 2010 and 2014 behavioral transactions created scale that would be difficult to reproduce facility by facility. More recently, the strategy has broadened from physical capacity toward digital access. UHS’s stated mission and operating principles emphasize quality care, service excellence and local accountability. Those principles matter financially because hospital growth is sustainable only when new capacity earns clinician trust, meets regulatory standards and reaches adequate occupancy.

Who owns UHS stock, and why does control matter?

UHS has a multi-class common-stock structure. Economic ownership is concentrated in Class B shares, but voting power is concentrated in Class A and Class C shares. The 2026 proxy statement, using ownership data as of March 23, 2026, shows that founder Alan B. Miller retained decisive influence over general voting matters.

88.9%Alan B. Miller’s disclosed general voting power as of March 23, 2026, despite owning different percentages of each share class.

How concentrated is voting control?

Holder or group Disclosed ownership Voting influence Why it matters
Alan B. Miller, Executive Chairman 5.11M Class A; 7.75M Class B; 661,688 Class C shares 88.9% general voting power Founder control supports strategic continuity but limits the ability of outside Class B holders to change direction.
Marc D. Miller, CEO and President 1.34M Class A and 2.19M Class B shares 2.3% general voting power Family leadership aligns succession with the founder-led operating model.
Directors and executive officers as a group 100% of Class A; 17.1% of Class B; 100% of Class C 91.8% general voting power Board elections and major corporate matters are heavily influenced by insiders.
First Eagle Investment Management 4.63M Class B shares; 8.6% of Class B Limited by Class B voting rights A large economic holder can engage management but cannot match insider voting control.
BlackRock 4.14M Class B shares; 7.7% of Class B Limited by Class B voting rights Passive institutional ownership adds governance scrutiny without transferring strategic control.

Class A and Class C represented only 11.9% of outstanding common shares but 91.3% of general voting power as of March 23, 2026; Class B and Class D represented 88.1% of shares but 8.7% of general voting power. This asymmetry is material for valuation and governance analysis. Outside investors participate economically in cash flows and buybacks, but founder-related holders can sustain long-horizon investments or resist strategic changes even when public-market sentiment shifts.

What opportunities and risks could change the story?

The opportunity case rests on sustained demand for hospital and behavioral services, better reimbursement yield, new capacity in attractive markets and expansion into virtual behavioral care. The risk case centers on government reimbursement, labor intensity, legal exposure, new-facility execution, cybersecurity and debt-funded capital allocation. These forces can operate simultaneously: a new hospital may expand long-term market share while depressing near-term margins, and a digital acquisition may broaden access while adding integration risk.

Opportunity
$835M
Approximate enterprise value of the proposed Talkspace transaction announced March 9, 2026, intended to add a national virtual behavioral platform.
Constraint
$1.28B
Net benefit from Medicaid supplemental payment programs in FY2025; a large policy-sensitive contributor to economics.

What could expand the addressable market?

The proposed Talkspace acquisition would add roughly 6,000 licensed professionals, access across all 50 states, Washington, D.C., and Puerto Rico, and more than 200 million eligible individuals as of December 31, 2025. Talkspace reported $229M of 2025 revenue and more than 1.6 million sessions. The transaction was expected to close in Q3 2026, subject to approvals and customary conditions. Strategically, it could connect UHS’s inpatient and outpatient behavioral network with a lower-capital digital channel and a broader commercial-payer mix.

Same-facility revenue yield
Watch revenue per adjusted admission. Q1 2026 growth of 6.3% acute and 6.2% behavioral did more work than volume.
New-hospital ramp
Track occupancy and pre-tax losses at Cedar Hill and Palm Beach Gardens as start-up capacity moves toward maturity.
Behavioral occupancy
Q1 2026 same-facility occupancy of available beds was about 74.0%; sustained utilization supports the segment’s margin advantage.
Talkspace closing and integration
Monitor regulatory approval, financing, payer retention, clinician retention and the promised first-year EPS contribution.
Labor ratios
Behavioral salary expense was 54.6% of same-facility revenue in Q1 2026; small changes can materially affect margin.
Cash conversion
Follow days sales outstanding, provider-payment timing and capex against the FY2026 range of $950M–$1.10B.

What could pressure earnings?

Risk Financial exposure Current factual anchor What to monitor
Medicare and Medicaid policy Revenue, uncompensated care and provider-tax economics $1.28B net supplemental-payment benefit, FY2025 Federal and state rulemaking, eligibility changes, directed-payment limits and renewal of state programs.
Labor availability and wages Salary ratio, staffed capacity and service quality 46.6% consolidated salary expense as a share of revenue, FY2025 Nursing vacancies, contract labor, wage growth and whether pricing offsets staffing costs.
Professional and general liability Cash claims, insurance cost and earnings volatility $449M self-insurance accrual, December 31, 2025 Major verdicts, reserve development, insurance terms and facility-specific litigation.
Geographic concentration Local regulation, payer mix and economic exposure Texas generated 16% of revenue; California 11%, FY2025 State reimbursement changes, population trends and competitor capacity additions.
Acquisition and leverage Interest expense, integration cost and capital flexibility $4.71B debt at March 31, 2026 Talkspace closing, borrowing costs, synergy realization and future repurchase pace.
Cybersecurity and compliance Operational disruption, privacy costs and regulatory penalties Enterprise-wide clinical and financial systems support hundreds of facilities Security investment, system availability, privacy incidents and regulatory findings.

Why does UHS matter for valuation, and what is the key takeaway?

A UHS valuation should not begin with a generic hospital revenue multiple. The company combines a lower-margin acute-care platform, a higher-margin behavioral platform, large policy-sensitive reimbursements, substantial recurring capital needs and a founder-controlled governance structure. A discounted cash flow model must therefore connect operating volume, revenue yield, labor ratios, capital spending, working capital, leverage and segment mix.

Which DCF assumptions carry the most weight?

Revenue growth
9.6%
Q1 2026 year-over-year growth. Test how much is sustainable when revenue per adjusted admission normalizes.
Operating margin
11.2%
Q1 2026 GAAP operating margin. Model acute and behavioral margins separately before consolidating.
Reinvestment
$950M–$1.10B
FY2026 expected capex. Separate maintenance, capacity growth and new-hospital ramp investment.
Terminal risk
Policy + labor
Long-run cash flow is sensitive to government reimbursement, provider taxes, wage inflation and clinical capacity.
Adjusted admissionsRevenue per adjusted admissionBehavioral occupancySalary ratioDays sales outstandingCapital expendituresDebt / EBITDASupplemental Medicaid payments

The central modeling tension is clear. UHS can grow earnings through price and mix even when admissions are modest, and its behavioral segment converts revenue into segment profit more efficiently than acute care. Yet the company must continually reinvest in physical facilities, staffing, technology and compliance. Buybacks can enhance per-share results, but they compete with acquisitions and capital projects for the same cash. The proposed Talkspace transaction adds a potentially attractive digital growth channel, while also increasing integration and financing complexity.

For students, UHS is a useful case in portfolio strategy, regulated pricing, operating leverage and governance. For researchers, the most revealing comparison is not simply UHS versus another hospital company; it is acute care versus behavioral health inside UHS. For investors, the decisive evidence will come from same-facility revenue yield, labor ratios, behavioral occupancy, cash conversion, supplemental-payment durability, new-hospital ramp losses and leverage after the proposed acquisition.

Final analytical takeaway
Universal Health Services matters because it combines a large regional acute-care platform with a behavioral-health network that produces the majority of combined segment profit. The story is supported by scale, local market density, strong FY2025 profitability, 9.6% Q1 2026 revenue growth and continued cash generation. It could weaken if reimbursement policy reduces supplemental payments, labor costs rise faster than pricing, new hospitals fail to mature, legal liabilities expand or debt-funded growth reduces flexibility. The most useful next-quarter test is whether UHS can preserve behavioral margins and acute-care cash conversion while translating higher revenue per patient into durable free cash flow rather than temporary working-capital gains.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.